Vivimusta 100 mg/4 mL (25 mg/mL) injection Images
Generic Name: bendamustine
This medication has been identified as Vivimusta 100 mg/4 mL (25 mg/mL) injection. It is supplied by Slayback Pharma LLC.
Vivimusta is used in the treatment of Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Vivimusta 100 mg/4 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vivimusta
- Generic Name
- bendamustine
- Strength
- 100 mg/4 mL (25 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Slayback Pharma LLC
- National Drug Code (NDC)
- 71225-0120
More about Vivimusta (bendamustine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
